Vimarsana
Biggest News Aggregation in the World

Page 15 - Vitro Diagnostics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Vitro Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Vitro Diagnostics Today - Breaking & Trending Today

Non-Invasive Prenatal Testing Market Size to Surpass USD - Vimarsana News

Non-Invasive Prenatal Testing Market Size to Surpass USD

As per the report by Fortune Business Insights, the global Non-Invasive Prenatal Testing Market size is projected to reach USD 19.09 billion in 2030, at a...

WHO releases new list of essential diagnostics - Vimarsana News

WHO releases new list of essential diagnostics

He World Health Organization (WHO) has released its 2023 Essential Diagnostics List (EDL), which is an evidence-based register of in vitro diagnostics (IVD) that supports countries to make national diagnostic choices. This year’s list includes two firsts: Inclusion of three tests for hepatitis E virus (HEV), including a rapid test to aid in the diagnosis

Fluorescent in Situ Hybridization (FISH) Probe Market Dominated by Instrument/Software Segment, but Consumables Poised for Significant Growth - Vimarsana News

Fluorescent in Situ Hybridization (FISH) Probe Market Dominated by Instrument/Software Segment, but Consumables Poised for Significant Growth

/PRNewswire/ -- The "Global Fluorescent in Situ Hybridization (FISH) Probe Market: (by Product, Technology, End User, Application, & Region): Insights and...

WHO releases new list of essential diagnostics; new recommendations for hepatitis E virus tests, personal use glucose meters - Vimarsana News

WHO releases new list of essential diagnostics; new recommendations for hepatitis E virus tests, personal use glucose meters

The World Health Organization (WHO) has released its 2023 Essential Diagnostics List (EDL), which is an evidence-based register of in vitro diagnostics (IVD) that supports countries to make national diagnostic choices.

Source: who.int
FDA's Proposed Rule on LDT Regulation and the Debate over Agency Deference | Sheppard Mullin Richter & Hampton LLP - Vimarsana News

FDA's Proposed Rule on LDT Regulation and the Debate over Agency Deference | Sheppard Mullin Richter & Hampton LLP

Earlier this month, the Food and Drug Administration (“FDA” or “the Agency”) issued a highly anticipated proposed rule outlining the regulatory framework and implementation plan for...